alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Ray SANDSTROM, Appellant, v. CITY OF FORT LAUDERDALE, Appellee.

No. 71-281.

District Court of Appeal of Florida, Fourth District.

July 20, 1971.

Ray Sandstrom, of Sandstrom & Hodge, Fort Lauderdale, for appellant.

Thomas P. Quinn, III, and Bryson K. Lovejoy, Sp. Asst. City Prosecutor, Fort Lauderdale, for appellee.

PER CURIAM.

Mr. Sandstrom was convicted in the Municipal Court of the City of Fort Lau-derdale of engaging in the occupation of attorney-at-law without first having obtain*342ed a municipal occupational license as required by ordinance. The conviction was affirmed on appeal to the circuit court, and a further appeal to the Supreme Court resulted in the cause being transferred to this court for disposition. We treat the appeal as a petition for writ of certiorari and deny the same upon the authority of Sandstrom v. City of Fort Lauderdale, Fla.App.1961, 133 So.2d 755; Louis K. Liggett Co. v. Amos, 1932, 104 Fla. 609, 141 So. 153; Singer Sewing Machine Co. v. Brickell, 1914, 233 U.S. 304, 34 S.Ct. 493, 58 L.Ed. 974; Southwestern Oil Co. v. Texas, 1910, 217 U.S. 114, 30 S.Ct. 496, 54 L.Ed. 688; Campbell Baking Co. v. City of Harrisonville, 8 Cir. 1931, 50 F.2d 670; Kaufman v. City of Tucson, 1967, 6 Ariz.App. 429, 433 P.2d 282; Fox Bakersfield Theatre Corp. v. City of Bakersfield, 36 Cal.2d 136, 222 P.2d 879, and 9 McQuillin, Law of Municipal Corporations, 3rd Edition, § 26.60.

Certiorari denied.

REED, C. J., and WALDEN and OWEN, JJ., concur.
[Federal Register Volume 62, Number 217 (Monday, November 10, 1997)]
[Notices]
[Page 60530]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29526]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Digital Imaging Group, Inc.

    Notice is hereby given that, on September 25, 1997, pursuant to 
Sec. 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. Sec. 4301 et seq. (``the Act''), the Digital Imaging 
Group, Inc. (``Consortium'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the identities of the parties and (2) the 
nature and objectives of the venture. The notifications were filed for 
the purpose of invoking the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances. 
Pursuant to Sec. 6(b) of the Act, the identities of the parties are: 
Adobe Systems Incorporated, San Jose, CA; Canon Inc., Tokyo, Japan; 
Eastman Kodak Company, Rochester, NY; Hewlett-Packard Company, San 
Diego, CA; IBM Corporation, Armonk, NY; Intel Corporation, Hillsboro, 
OR; Fuji Photo Film Co., Ltd., Tokyo, Japan.
    Digital Imaging Group, Inc. was formed as a Delaware non-stock 
member corporation. The primary objective of the venture is to promote 
the growth of digital imaging by defining and publishing the 
``FlashPix'' format and Internet Digital Imaging Protocol, and other 
deliverables that the Board of Directors may direct from time to time, 
which will contribute to making digital images a pervasive data type in 
computers, across networks, and within communication devices of the 
future.
    Membership in the Consortium will remain open and the Consortium 
will file additional written notifications disclosing all changes in 
membership.
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 97-29526 Filed 11-7-97; 8:45 am]
BILLING CODE 4410-11-M
Exhibit 10.8


 


EXECUTION COPY


 


AMENDMENT NO. 1 TO THE


DEFERRED COMPENSATION AGREEMENT


WITH JOHN C. WILLIAMS


 


This AMENDMENT NO. 1 (this
“Amendment”) to the deferred compensation agreement between Jacksonville Savings Bank (the “Bank”)
and John C. Williams is hereby entered on January 17, 2018.


 


WHEREAS, Chapin
State Bank, the predecessor to the Bank, entered into a deferred compensation agreement with Mr. Williams on August 3, 1987 (the
“Agreement”); and


 


WHEREAS, the Bank
is a wholly-owned subsidiary of Jacksonville Bancorp, Inc. (“Jacksonville”); and


 


WHEREAS, Jacksonville,
CNB Bank Shares, Inc. and CNB Acquisitions, Inc. have entered into an Agreement and Plan of Merger dated as of January 17, 2018
(the “Merger Agreement”); and


 


WHEREAS, following
the completion of the transactions contemplated by the Merger Agreement (the “Merger”), the Agreement shall
be assumed by any successor to the Bank pursuant to the terms of the Agreement as amended by this Amendment.


 


NOW, THEREFORE,
in consideration of the premises, the mutual agreements herein set forth and such other consideration the sufficiency of which
is hereby acknowledged, the Agreement is hereby amended as follows:


 


1.          Deletion
of Section 3 of the Agreement. Section 3 of the Agreement is hereby deleted in its entirety.


 


2.          Amendment
to Section 4 of the Agreement. Section 4 of the Agreement is hereby amended and restated to read as follows:


 


“4         NO
ACCELERATION OF BENEFIT PAYMENTS. No acceleration of the time or schedule of any payment may be made pursuant to this Agreement,
unless both written consent is received from the Director and such earlier distribution does not result in adverse tax consequences
under Section 409A of the Internal Revenue Code of 1986, as amended.”


 


3.          Capitalized
Terms. Capitalized terms herein shall have the meanings ascribed to them in the Agreement except as otherwise expressly
provided in this Amendment.


 


4.          Effect
of Amendment. Except and to the extent modified by this Amendment, the provisions of the Agreement shall remain in full
force and effect and are hereby incorporated into and made a part of this Amendment.


 




    	 	 	 



     


    

  


5.          Effective
Date. This Amendment shall become effective on the date on which the Effective Time occurs. In the event the Merger Agreement
is terminated by the parties thereto without the transactions contemplated thereby having been consummated, this Amendment shall
be deemed null and void ab initio.


 


[Signature Page Follows]


 




    	 	2	 



     


    

  


IN WITNESS WHEREOF, the parties below
have executed this Amendment as of the date first written above.


 


	 	JACKSONVILLE SAVINGS BANK
	 	 	 
	 	By:	/s/ Richard A. Foss
	 	Name:	Richard A. Foss
	 	Title:	President and CEO
	 	 	 
	 	DIRECTOR
	 	 	 
	 	/s/ John C. Williams
	 	John C. Williams


 








    	 	3
# 1. Benefit

# 2. Counts

# 3. All

# 4. EITC

# 5. ACTC

# 6. AOTC
I 

117TH CONGRESS 

1ST SESSION H. R. 1875 

To amend title XXVII of the Public Health Service Act to eliminate the 

short-term limited duration insurance exemption with respect to individual health insurance coverage. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 12, 2021 

Ms. CASTOR of Florida (for herself and Mr. HIGGINS of New York) introduced 

the following bill; which was referred to the Committee on Energy and 

Commerce 

A BILL 

To amend title XXVII of the Public Health Service Act 

to eliminate the short-term limited duration insurance 

exemption with respect to individual health insurance 

coverage. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ELIMINATING THE SHORT-TERM LIMITED DU4 RATION INSURANCE EXEMPTION WITH RE5 SPECT TO INDIVIDUAL HEALTH INSURANCE 

6 COVERAGE. 

7 Section 2791(b)(5) of the Public Health Service Act 

8 (42 U.S.C. 300gg–91(b)(5)) is amended by inserting 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 1875 IH

1 ‘‘(other than such insurance that is issued, sold, or re2 newed on or after January 1, 2023)’’ before the period 

3 at the end. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS
----

**EXHIBIT      32.2**

**CERTIFICATION      PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO § 906 OF THE**

**SARBANES-OXLEY      ACT OF 2002**

|   | (1) | the                  Report fully complies with the requirements of § 13(a) or 15(d) of the                  Securities Exchange Act of 1934, as amended;                  and |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | the                  information contained in the Report fairly presents, in all material                  respects, the financial condition and results of operations of                  the                  Company. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:                    August 8, 2006 | By:    | /s/                    Charles N. Eldred      |
|-----------------------------------------|--------|-----------------------------------------------|
|                                    |   | Charles                    N. Eldred          |
|                                    |   | Senior                    Vice President, and |
|                                    |   | Chief                    Financial Officer    |
<PAGE>
                                EXHIBIT 99 (1)

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Quarterly Report of Coastal Caribbean Oils &
Minerals, Ltd. (the "Company") on Form 10-Q for the period ending March 31, 2003
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Phillip W. Ware, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Company.




Date:  May 12, 2003                                       By /s/ Phillip W. Ware
                                                          ----------------------
                                                          Phillip W. Ware
                                                          President



A signed original of this written statement required by Section 906 has been
provided to Coastal Caribbean Oils & Minerals, Ltd. and will be retained by
Coastal Caribbean Oils & Minerals, Ltd. and furnished to the Securities and
Exchange Commission or its staff upon request.
[Federal Register Volume 62, Number 220 (Friday, November 14, 1997)]
[Notices]
[Page 61129]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29970]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


The National Immunization Program (NIP) of the Centers for 
Disease Control and Prevention (CDC); Meeting

    Name: Adolescent Immunization Meeting.
    Time and Date: 7:30 a.m.-4 p.m. December 4, 1997.
    Place: J.W. Marriott Hotel, Lenox, 3300 Lenox Road, NE Atlanta, 
Georgia 30326. Telephone 404/262-3344, fax 404/262-8803.
    Status: The meeting is open to the public subject to the 
availability of conference room space. The meeting will be a round 
table discussion with public and private medical providers and 
experts who deal with adolescent health and immunization issues. 
Written comments will be accepted during the meeting or at the 
address below. Attendees must provide and pay for their own travel 
expenses.
    Purpose: The meeting will bring together a small group of public 
and private medical experts, in adolescent health and immunization, 
to collaborate with the CDC in developing adolescent immunization 
disease reduction and coverage goals/objectives.
    Matters To Be Discussed: CDC speakers will present background 
information; sample goals/objectives; year 2000 and possible 2010 
Healthy People objectives; and other adolescent immunization health 
information. In addition, CDC speakers will describe vaccine-
preventable diseases associated with adolescents and estimated 
immunization coverage levels.
    Specific agenda items include adolescent immunization coverage 
goals; coverage estimates for childhood and adolescent immunization; 
adolescent disease reduction goals; epidemiology of vaccine 
preventable diseases in adolescents; implementation perspectives; 
HEDIS 3.0 adolescent immunization measures; and managed care 
organization adolescent immunization policies.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Edith Gary, Health Services 
Research and Evaluation Branch, Immunization Services Division, CDC, 
NIP, 1600 Clifton Road, NE, M/S E-52, Atlanta, Georgia 30333. 
Telephone 404/639-8209, fax 404/639-8615, e-mail <a href="/cdn-cgi/l/email-protection#77120f10463714131459101801"><span class="__cf_email__" data-cfemail="ed88958adcad8e898ec38a829b">[email protected]</span></a>.

    Dated: November 7, 1997.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-29970 Filed 11-13-97; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32.1

                                  CERTIFICATION
                           Pursuant to 18 U.S.C. 1350
                 (Section 906 of the Sarbanes-Oxley Act of 2002)

In connection with the Annual Report on Form 10-K of Logan Sound Inc. (the
"Company") for the year ended April 30, 2011, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Ken Logan, as
Chief Executive Officer and Chief Financial Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


Dated: February 18, 2014                  By: /s/ Ken Logan
                                             -----------------------------------
                                             Ken Logan, President and
                                             Chief Executive Officer and
                                             Chief Financial Officer

This certification accompanies each Report pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of ss.18
of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 62, Number 218 (Wednesday, November 12, 1997)]
[Notices]
[Page 60725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29670]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Diabetes and Digestive and Kidney Diseases 
Special Emphasis Panel meetings:

    Name of SEP: ZDKI-GRB-6-J-3.
    Date: December 9, 1997.
    Time: 11:00 am.
    Place: Room 6as-25E, Natcher Building, NIH (Telephone Conference 
Call).
    Contact Person: Sharee Pepper, Ph.D., Scientific Review 
Administrator, Review Branch, DEA, NIDDK, Natcher Building, Room 
6as-25E, National Institutes of Health, Bethesda, Maryland 20892-
6600, Phone: (301) 594-7798.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: ZDKI-GRB-4.
    Date: December 12, 1997.
    Time: 8:30 am.
    Place: Doubletree Guest Suites, 1300 Concourse Drive, Linthicum, 
Maryland 21090.
    Contact Person: William Elzinga, Ph.D., Scientific Review 
Administrator, Review Branch, DEA, NIDDK, Natcher Building, Room 
6as-37A, National Institutes of Health, Bethesda, Maryland 20892-
6600, Phone: (301) 594-8895.

    These meetings will be closed in accordance with the provisions 
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program No. 93.847-849, 
Diabetes, Endocrine and Metabolic Diseases; Digestive Diseases and 
Nutrition; and Kidney Diseases, Urology and Hematology Research, 
National Institutes of Health)

    Dated: November 3, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-29670 Filed 11-10-97; 8:45 am]
BILLING CODE 4140-01-M
## IN THE COURT O F CRIMINA L A PPEA LS OF TEXAS NO. WR-84,598-01
EX P ARTE JUSTIN CAIN TOL AR, Applicant
ON AP P LICATION FOR A WRIT OF HABEAS CORP US CAUSE NO. 22938 IN THE 258 DISTRICT COURT T H F ROM P OLK COUNTY
Per curiam . O PI N I O N Pursuant to the provisions of Art i cl e 1 1
. 07 of the Texas Code of Criminal Procedure, the cler k of the trial court transmitted to this Court this application for a writ of habea s corpus. Ex parte Y oung , 418 S.W .2d 824, 826 (Tex. Crim. App. 1967). Applicant was convicted of cre dit card abuse and sentenc ed to twenty year s’ imprisonment. The Ninth Court of Appea ls aff irmed his conviction. Tolar v. State , No. 09-13-00482- CR (Tex. App.—Bea umont April 1, 2015). Applicant contends that he was denied the right to file a pro se petition for d i s cr et i onary revie w beca

use he not rec eived timely notice that his conviction had been aff irmed. Appellate counsel filed an aff

idav i t wi th the trial court. Ba sed on that aff idavit, the trial court has enter ed2

finding s of fac t and conclusions of law that Applicant did not rec eive timely notice of the appellate court’s decision. The trial court rec ommends that relief be grante d. Ex parte Riley , 193 S.W .3d 900 (Tex. Crim. App. 2003). We find, there fore , that Applicant is entitled to the opportunity to file an out-of-time petition for discretionar

y review of the judgme nt of the Ninth Court of Appea ls in Cause No. 09-13-00482- CR that aff

irmed his conviction in Cause No. 22938 from the 258 District Court of Polk County
. th Applicant shall file his petition for discre tionary revie w with this Court within 30 day s of the date on which this Court’s mandate issues.

Deliver ed: Marc h 2, 2016 Do not publish
-80 -78 -76 -74 -72

36 38 40 

### ★ ▲ ▲ ▲ ▲



### ★ ▲ ▲ ▲ ▲ 500 1000 1500 100 18 12 06 00 06/26 

### NOAA HYSPLIT MODEL 

## Backward trajectory ending at 2300 UTC 26 Jun 07

EDAS Meteorological DataSource★at 39.56 N 76.20 WMeters AGL
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Exhibit 31.3

Certification of Co-Chief Executive Officer

Pursuant to Section 302
of the Sarbanes-Oxley Act of 2002

I, Clark A. Marcus, certify that:

1. I have reviewed this Amendment No. 1 to this quarterly report on Form 10-Q of Comprehensive Care Corporation; and

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report,

|                  |  |  |  |                                     
|----------------- |  |  |  | ------------------------------------
|                  |  | 
|                  |  |  |  | /s/ CLARK A. MARCUS                 
|December 17, 2010 |  |  |  | Clark A. Marcus                     
|                  |  |  |  | Chief Executive Officer and Chairman
|                  |  |  |  | (Principal Executive Officer)
#### In re ESTATE of S. W. GRANBERRY, Deceased.

No. K-491.

District Court of Appeal of Florida. First District.

July 17, 1969.

Truett & Watkins, Tallahassee, for appellant.

Thomas C. Wilkinson, Marianna, for ap-pellee.

PER CURIAM.

This cause having been orally argued before the court, the briefs and record on appeal having been read and given full consideration, and appellants having failed to demonstrate reversible error, the judgment of the lower court thereby appealed is affirmed.

CARROLL, DONALD K., Acting C. J., and WIGGINTON and SPECTOR, JJ., concur.
STEAM ELECTRIC CBI REPLACEMENT PAGE

EPA

- HQ

- OW

- 200 9-0 819

DCN: SE0396 8

THE FOLLOWING HAS BEEN REMOVED BECAUSE IT

CONTAINS CONFIDENTIAL BUSINESS I NFORMATION

(CBI) PER 40 CFR PART 2, SUBPART B.